Immunotherapy
Approved for: SCLC

Pembrolizumab (Keytruda) is a FDA-approved treatment for small cell lung cancer (SCLC) that has metastasized. It is used in patients whose disease got worse during or after treatment with platinum chemotherapy and at least one other therapy.

Related Research News